| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 08/22/2006 | US7094411 Avirulent, immunogenic flavivirus chimeras |
| 08/22/2006 | US7094408 Immunogenicity using a combination of DNA and vaccinia virus vector vaccines |
| 08/22/2006 | US7094405 Peptides which elicit a high neutralizing antibody titer, cytotoxic T lymphocyte response and T helper cell response in a broad range of MHC type recipients |
| 08/22/2006 | US7094403 Mycobacterium tuberculosis superoxide dismutase |
| 08/22/2006 | US7094392 Heating antihistamine drug vaporize; cooling to form a condensation aerosol; kit for dispensing thin coating |
| 08/22/2006 | CA2368138C Mechanically stable pharmaceutical presentation form containing liquid or semisolid surface-active substances |
| 08/17/2006 | WO2006085932A2 Anti-viral uses of borinic acid complexes |
| 08/17/2006 | WO2006085797A1 Hypodermic medicinal agent against human candidosis |
| 08/17/2006 | WO2006085747A1 Controlled release compositions for interferon based on pegt/pbt block copolymers |
| 08/17/2006 | WO2006085688A1 Psychogenic pain therapeutic agent |
| 08/17/2006 | WO2006085627A1 Cream loaded with shellfish firing product powder and process for producing the same |
| 08/17/2006 | WO2006085607A1 Plant component-containing emulsion preparation and method for producing the same |
| 08/17/2006 | WO2006085553A1 Anti-tlr6 antibody and utilization of the same |
| 08/17/2006 | WO2006085411A1 Novel adjuvant for evoking immune responce and utilization of the same |
| 08/17/2006 | WO2006085337A1 Parenteral combination therpy for infective conditions with drug resistant bacterium |
| 08/17/2006 | WO2006085212A2 Condensed isoxaline derivatives as inhibitors of phosphodiesterase type-iv |
| 08/17/2006 | WO2006085199A1 Piperazine derivatives |
| 08/17/2006 | WO2006085067A1 Atm inhibitors |
| 08/17/2006 | WO2006084758A1 Human monoclonal antibody specific for lipopolysaccharides (lps) of the pseudomonas aeruginosa iats o11 serotype |
| 08/17/2006 | WO2006084741A1 Substance for the treatment of infections |
| 08/17/2006 | WO2006084477A1 Use of a lyophilised bacterial lysate for the prevention of tuberculosis relapse |
| 08/17/2006 | WO2006084467A1 Surface-located streptococcus pneumoniae polypeptides |
| 08/17/2006 | WO2006084463A1 Systemic treatment of infections with defensins |
| 08/17/2006 | WO2006084410A1 New macrolides |
| 08/17/2006 | WO2006084337A1 A molecule and chimeric molecules thereof |
| 08/17/2006 | WO2006084327A1 A molecule and chimeric molecules thereof |
| 08/17/2006 | WO2006060730A3 Potassium salt of an hiv integrase inhibitor |
| 08/17/2006 | WO2006056031A8 Use of ferrous ions for increasing the immunoreactivity of immunoglobulin preparations |
| 08/17/2006 | WO2006052373A3 Method for treating hiv infection through co-administration of tipranavir and etravirine |
| 08/17/2006 | WO2006007384B1 Antibiotics containing borinic acid complexes and methods of use |
| 08/17/2006 | US20060183908 Heterocyclic compounds, methods of making them and their use in therapy |
| 08/17/2006 | US20060183890 Isopropanolate of azithromycin and method of manufacturing |
| 08/17/2006 | US20060183886 Ligands to enhance cellular uptake of biomolecules |
| 08/17/2006 | US20060183805 Non-oxidatively metabolized compounds and compositions, synthetic pathways therefor, and uses thereof |
| 08/17/2006 | US20060183770 Sulfonamide derivative having isoxazole ring |
| 08/17/2006 | US20060183762 3-aminoquinazolin-2,4-dione antibacterial agents |
| 08/17/2006 | US20060183760 (2S3R)-3-{9-Isopropyl-6-[(pyridin-2-ylmethyl)-amino]-9H-purin-2-ylamino}-pentan-2-ol; treating proliferative disorders, viral disorders, CNS disorders, diabetes, stroke, alopecia or neurodegenerative; cancer, leukemia, psoriasis; cyclin-dependent kinase (CDK) inhibitors |
| 08/17/2006 | US20060183731 7 and 8 membered heterocyclic cyclopentyl benzylamide modulators of chemokine receptor activity |
| 08/17/2006 | US20060183730 Novel carbapenem compounds |
| 08/17/2006 | US20060183673 Antibiotic 107891, its factors a1 and a2, pharmaceutically acceptable salts and compositions, and use thereof |
| 08/17/2006 | US20060183664 Pharmaceutical composition for delayed hypersensitivity |
| 08/17/2006 | US20060183191 Synthetic approach to designed chemical structures |
| 08/17/2006 | US20060182813 Colloidal silver composition having microbial properties |
| 08/17/2006 | US20060182741 Use of adcc-optimized antibodies for treating weak patients |
| 08/17/2006 | CA2597489A1 Surface-located streptococcus pneumoniae polypeptides |
| 08/17/2006 | CA2597346A1 A molecule and chimeric molecules thereof |
| 08/17/2006 | CA2597191A1 Antimicrobial hexapeptides |
| 08/17/2006 | CA2594434A1 Controlled release compositions based on block copolymers |
| 08/17/2006 | CA2594408A1 Device and method for treatment of dermatomycosis, and in particular onychomycosis |
| 08/17/2006 | CA2576425A1 Compositions and methods for treating or preventing hepadnaviridae infection |
| 08/17/2006 | CA2570577A1 Anti-viral uses of borinic acid complexes |
| 08/17/2006 | CA2563109A1 Anti-hiv quinuclidine compounds |
| 08/16/2006 | EP1690941A1 Papilloma virus capsomere vaccine formulations and methods of use |
| 08/16/2006 | EP1690875A1 Human monoclonal antibody specific for lipopolysaccharides (LPS) of the pseudomonas aeruginosa IATS O11 serotype |
| 08/16/2006 | EP1690545A2 A combination therapy for HIV infections |
| 08/16/2006 | EP1689795A1 Method of manufacture of polyacrolein |
| 08/16/2006 | EP1689770A1 Depeptidized inhibitors of hepatitis c virus ns3 protease |
| 08/16/2006 | EP1689755A2 Processes for the preparation of highly pure 3-(2-substituted vinyl) cephalosporin |
| 08/16/2006 | EP1689739A1 Azole-based kinase inhibitors |
| 08/16/2006 | EP1689731A1 2-phenyl-benzofuran derivatives, method for the production thereof and their use |
| 08/16/2006 | EP1689698A1 Bis-cationic compounds and use thereof |
| 08/16/2006 | EP1689434A1 The use of anti biotics as vaccine adjuvants |
| 08/16/2006 | EP1689416A1 Disinfecting composition and methods of making and using same |
| 08/16/2006 | EP1689405A1 Thioridazine and derivatives thereof for reversing anti-microbial drug-resistance |
| 08/16/2006 | EP1689388A1 Association of antimicrobial compounds with surfaces and polymers |
| 08/16/2006 | EP1404678B1 Water-soluble porphyrin derivatives for photodynamic therapy, their use and manufacture |
| 08/16/2006 | EP1399476B1 Use of soluble cytokeratine-1-fragments in diagnostics |
| 08/16/2006 | EP1363930B1 A method for generating genetically altered antigens |
| 08/16/2006 | EP1318991B1 Benzoic acid derivatives and uses thereof |
| 08/16/2006 | EP1301467B1 9-substituted minocycline compounds |
| 08/16/2006 | EP1276853B1 Pneumovirus ns proteins antagonising the interferon (ifn) response |
| 08/16/2006 | EP1268530B1 Hepatitis b core antigen fusion proteins |
| 08/16/2006 | EP1261603B1 Flavone derivatives, preparation method and use as medicines |
| 08/16/2006 | EP1198233B1 Sulfonamide and sulfamide substituted imidazoquinolines |
| 08/16/2006 | EP1137410B1 Novel 4-dedimethyl aminotetracycline derivatives |
| 08/16/2006 | EP1087941B1 Thiolesters and uses thereof |
| 08/16/2006 | EP0314705B2 A novel family of primate hematopoietic growth factors |
| 08/16/2006 | CN1820078A Recombinant mutants of rhabdovirus and methods of use thereof |
| 08/16/2006 | CN1820019A Antimicrobial polypeptides |
| 08/16/2006 | CN1820012A Organosilicon compounds and their use |
| 08/16/2006 | CN1820004A Benzofuran derivatives and their use in the treatment of microbial infections |
| 08/16/2006 | CN1819990A Compound having anti-hcv activity and process for producing the same |
| 08/16/2006 | CN1819845A Medicinal composition containing NF-kappa B decoy for treating and preventing respiratory diseases and method of using the same |
| 08/16/2006 | CN1819834A Agent for inhibiting membrane virus reproduction, method for the production thereof, pharmaceutical composition and method for inhibiting viral infections |
| 08/16/2006 | CN1819825A Amino acid iodine composition, its production and use thereof |
| 08/16/2006 | CN1817901A Therapeutic peptides and method |
| 08/16/2006 | CN1817889A Antiviral medicine with rare earth of heteropoly compound |
| 08/16/2006 | CN1817868A Group of ornidazole deriative for preventing anaerobe infection and production thereof |
| 08/16/2006 | CN1817866A Group of geldanamycin derivative with nucleoside base |
| 08/16/2006 | CN1817851A N-substituted-w-amino-1,2,3,4-tetrahydronaphthalene compounds with antifungal activity and their salts |
| 08/16/2006 | CN1817849A Diphenyl heptanone compound, its production and use |
| 08/16/2006 | CN1817368A Vaccine for reticuloendothliosis of poultry and preparing method thereof |
| 08/16/2006 | CN1817367A Activation and inhibition of the immune system |
| 08/16/2006 | CN1817350A Silkworm sand total alkaloid and preparation thereof |
| 08/16/2006 | CN1817349A Nucleoside analogues with carboxamidine-modified monocyclic base |
| 08/16/2006 | CN1817346A Benzoyl metronidazole dispersion tablets and preparation thereof |
| 08/16/2006 | CN1817345A Miglinon drops and preparing method thereof |
| 08/16/2006 | CN1817340A Composition of sodium fusidafe as injection and preparing method thereof |
| 08/16/2006 | CN1269840C Human interferon analogue with long-lasting biological effects |
| 08/16/2006 | CN1269837C Serial synthetic antibacterial peptide |